News

DC CFAR investigators are highly active in local, national and international HIV/AIDS research.  Learn more about the latest research and funding news. 

Natural Product Derived CXCR4/CCR2 Dual-targeted Fusion Inhibitors

September 01, 2011

X. Simon Wang, PhD has received a NIH CFAR Administrative Supplement to conduct virtual screening of potential CXCR4/CCR2 dual targeting fusion inhibitors. Dr. Wang is an Assistant Professor in the Department of Pharmaceutical Sciences at Howard University.

Microvascular Endothelial Function and Aging in Patients with HIV/AIDS

September 01, 2011

Dan Wang, MD, PhD has been awarded a NIH CFAR Administrative Supplement to collect preliminary data on microvascular function and perivascular adipose tissue signaling in older adults. Dr. Wang is a Research Associate Professor at the Georgetown University School of Medicine.

Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS

September 01, 2011

Alan E. Greenberg, MD, MPH has been awarded a parent award for the ECHPP Initiative. Dr. Greenberg is the Director of the DC D-CFAR and a Professor and Chair in the Department of Epidemiology and Biostatistics at the George Washington University.

GWU Support of ECHPP Initiative

September 01, 2011

Amanda D. Castel, MD, MPH has been awarded NIH CFAR Administrative Supplemental funding to evaluate current DC linkage to care and assess the feasibility of PrEP in the district. Dr. Castel is an Assistant Professor in the Department of Epidemiology and Biostatistics at the George Washington University.

Microvascular Targeting Drug (ARV)-Loaded Multifunctional Nanoparticles to M Cells Overlaying GALT (HIV-1 Reservoir)

September 01, 2011

Emmanuel Akala, PhD, RpH, MSc was awarded a NIH CFAR Administrative Supplement for his work utilzing nanoparticles to deliver antiretroviral drugs. Dr. Akala is an Associate Professor of Pharmaceutical Sciences at Howard University.